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Human inﬂuenza A viruses are known to be transmitted via the air from person to person. It
is unknown from which anatomical site of the respiratory tract inﬂuenza A virus transmission
occurs. Here, pairs of genetically tagged and untagged inﬂuenza A/H1N1, A/H3N2 and
A/H5N1 viruses that are transmissible via the air are used to co-infect donor ferrets via the
intranasal and intratracheal routes to cause an upper and lower respiratory tract infection,
respectively. In all transmission cases, we observe that the viruses in the recipient ferrets are
of the same genotype as the viruses inoculated intranasally, demonstrating that they are
expelled from the upper respiratory tract of ferrets rather than from trachea or the lower
airways. Moreover, inﬂuenza A viruses that are transmissible via the air preferentially infect
ferret and human nasal respiratory epithelium. These results indicate that virus replication in
the upper respiratory tract, the nasal respiratory epithelium in particular, of donors is a driver
for transmission of inﬂuenza A viruses via the air.
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M illions of people have lost their lives due to inﬂuenza Avirus (IAV) epidemics and pandemics. Prevention andcontrol of IAV infections are based on vaccination and
treatment. However, a better fundamental understanding of IAV
transmission could help to design additional appropriate inter-
vention strategies, especially in health care settings. Transmission
of IAVs between humans can occur via direct or indirect person-
to-person contact and through the air via respiratory droplets or
aerosols. The relative contribution of each route of transmission
is still under debate1–3, yet it is widely accepted that aerosol or
respiratory droplet transmission is the key factor for the rapid
spread and continued circulation of IAVs in humans. Evidence
for this transmission route is supported by the direct detection of
inﬂuenza virus genomes and viable inﬂuenza virus particles in
aerosols and/or respiratory droplets from breathing4–7, sneezing
or coughing individuals6,8–11, and in the air in hospitals and
healthcare settings12–15. Moreover, transmission of IAVs via the
air is also supported by animal studies in ferrets16–18 and guinea
pigs19,20. In the ferret transmission model, pandemic and sea-
sonal IAVs isolated from humans are transmitted from an
infected donor ferret to an exposed recipient ferret via the air,
whereas avian inﬂuenza viruses are generally not21. Our ferret
transmission model does not allow distinction between trans-
mission via aerosols or respiratory droplets; therefore, the ter-
minology “airborne” transmission will be used in the rest of this
manuscript when referring to aerosols and/or respiratory droplet
transmission.
The ferret transmission model has also been used to investigate
the viral properties that are necessary for airborne transmission of
IAVs21–25. Among them is the binding of the hemagglutinin
(HA), one of the virus surface glycoproteins, to sialic acids (SA)
receptors linked to the penultimate sugar, galactose, by a α2,6
linkage (α2,6-SA)21–25. In general, the HA of human(-adapted)
IAVs preferentially recognizes α2,6-SA, whereas that of avian
IAVs preferentially binds to α2,3-SA26,27. In humans, α2,6-SA
receptors are predominantly present on ciliated cells in the upper
respiratory tract (URT), i.e., in the nasal turbinates, paranasal
sinuses, pharynx and larynx, and in the upper part of the lower
respiratory tract (LRT), i.e., in the trachea and bronchus28,29. In
contrast, α2,3-SA receptors are mainly present on bronchiolar
non-ciliated cuboidal cells and alveolar type II pneumocytes of
the LRT28,29. However, it still remains unknown from which
exact anatomical site of the respiratory tract airborne transmis-
sible IAVs are expelled and whether α−2,6-SA preference is
critical at the donor or recipient level, or both. To determine
whether airborne transmissible IAVs originate from tissues of the
URT or LRT, we here investigate the transmission of untagged
and genetically tagged variant IAVs30,31 upon simultaneous
inoculation at a different anatomical site: the URT or LRT of
ferrets. Our results demonstrate that airborne transmissible IAVs
are transmitted from the URT, more speciﬁcally from the nasal
turbinates of ferrets, which correlates with high infectivity in the
ferret and human nasal respiratory epithelium in vivo and
in vitro, respectively. Finally, the tropism for nasal respiratory
epithelium in ferrets is shown to be determined by mammalian
adaptation markers in the HA protein.
Results
The site of generation of airborne IAVs is the URT. In order to
understand from which anatomical site of the respiratory tract
airborne transmissible IAVs are expelled, untagged and
genetically tagged variant (var) versions of the A/Netherlands/
602/2009 virus (A/H1N1 and A/H1N1var)30 were used to
inoculate donor animals in the ferret transmission model18,32.
The A/H1N1var virus carries a single synonymous substitution
per gene segment, so that it can be differentiated from the A/
H1N1 virus. Two ferrets (Donor 1 and 2) were inoculated
intranasally with the A/H1N1 virus and intratracheally with the
A/H1N1var virus. Two additional ferrets were inoculated with
the opposite placement of viruses (Donor 3 and 4), in order to
correct for potential small differences in transmissibility as a
result of the introduced substitutions in the var virus. Four
hours after inoculation (hpi) of donor ferrets, recipient ferrets
were placed in an opposite cage separated by two steel grids,
10 cm apart, to avoid direct contact transmission. Throat and
nose swabs were collected from donor and recipient ferrets
every 24 and 12 h, respectively. The anatomical sites targeted by
the different inoculation routes and sampling methods are
shown schematically in Supplementary Fig. 1.
We have previously shown that double inoculations at different
anatomical sites of the respiratory tract of ferrets led to
compartmentalization of the viruses, which greatly restricted
reassortment30. Therefore, next-generation sequencing was
performed on only one gene, the PB2 gene, to determine whether
the throat and nose swabs collected from the donor and recipient
ferrets contained the A/H1N1, A/H1N1var viruses or a mix of
both viruses. For donor ferrets, swabs collected at 1-day post-
inoculation (dpi), at the day that transmission to recipient ferrets
was observed and at the last day that donor ferrets were virus
positive (as determined by virus titration) were processed for
next-generation sequencing. For recipient ferrets, the ﬁrst and the
last swabs that were positive (threshold value in RT-qPCR (Ct
value) < 35) were subjected to next-generation sequencing. Virus
inocula were also processed for next-generation sequencing to
conﬁrm clonality (see the “Methods” section).
In the nose swabs of donor ferrets, viruses were of the same
genotype as the virus that was inoculated in the nose (Fig. 1).
However, in the throat swabs of three out of four donor ferrets, a
low amount of the virus that was instilled in the LRT was also
detected (Donor 1 (day 1 (17.8%), day 4 (76.5%), day 6 (22.2%)),
donor 3 (day 1 (2.4%)) and donor 4 (day 1 (94.6%), day 5 (9.9%)
and day 6 (20.8%)). Airborne transmission occurred between all
four pairs of ferrets. Each time, the predominant viruses detected
in recipient ferrets were of the same genotype as the virus that
was inoculated intranasally in donor ferrets. Only very low
proportions of the A/H1N1var virus, which was inoculated in the
LRT, was detected in the throat swabs of Recipient 1 at 4 dpi
(2.6%) and at 7 dpi (2%). The virus that was used to inoculate
ferrets intratracheally was only detected in throat swabs collected
from three donor ferrets (donor 1, 3, and 4). Therefore, to allow
conﬁrmation that the virus instilled intratracheally was actively
replicating in the LRT, a similar experiment was conducted, and
this time the donor ferrets were euthanized when transmission to
recipient ferrets was demonstrated, or at the latest at 5 dpi
(donor/recipient pairs 5–8, Fig. 2 and in more detail in
Supplementary Fig. 2). Tissues of the different parts of the
respiratory tract (nasal turbinates, trachea (upper and lower part),
lung (left and right lobes)) were harvested and homogenized, and
subsequently subjected to virus titration and next-generation
sequencing. Furthermore, in order to study whether transmission
from the upper respiratory tract of donor ferrets would also be
observed with other airborne transmissible IAVs, similar
experiments were conducted using untagged and genetically
tagged (var) pairs of a human A/H3N2 virus (A/H3N2 and A/
H3N2var; A/Panama/2007/99; donor/recipients pairs 9–12; Fig. 2
and in more detail in Supplementary Fig. 3)33 and of an airborne
transmissible highly pathogenic avian inﬂuenza A/H5N1 virus
(A/H5N1AT and A/H5N1AT-var; A/Indonesia/5/2005 carrying
nine substitutions, see the “Methods section”; donor/recipient
pairs 13–16; Fig. 2 and in more detail in Supplementary Fig. 4)32.
The predominant virus genotypes detected in the nasal turbinates
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of all donor ferrets were the same as those detected in the nasal
swabs. In the throat swabs of all donor ferrets, mixtures of
untagged and tagged viruses were present, as observed in the ﬁrst
experiment with the A/H1N1 virus. In the trachea and lung
samples, the predominant virus genotype was that of the virus
that was inoculated intratracheally, with the exception of donor
10 (A/H3N2) and 15 (A/H5N1AT). However, in both cases, the
virus inoculated intratracheally was also detected, conﬁrming
that the virus instilled in the LRT was replicating. Titers in the
LRT of donor ferrets inoculated with the A/H3N2 virus
were lower than those in ferrets inoculated with A/H1N1 or A/
H5N1 viruses. However, viral RNA was ampliﬁed and sequenced
from each sample. A/H1N1, A/H3N2, and A/H5N1AT viruses
were transmitted via the airborne route between two out of four,
three out of four and two out of four donor/recipient pairs,
respectively. Transmission was deﬁned here by the detection of
two consecutive swabs with a threshold value in RT-qPCR (Ct
value) < 35. Despite the fact that infectious virus titers were
detected only in one throat swab of Recipient 13 (Supplementary
Fig. 4), viral RNA was ampliﬁed from the other swabs of
Recipient 13 and Recipient 15, allowing the characterization of
the nature of the virus that had transmitted. On all occasions
when airborne transmission was observed, the virus that was
inoculated intranasally in the donor ferrets was detected in the
swabs of recipient ferrets. Despite detection of a very low
proportion of the virus that was inoculated intratracheally in the
donors in a minority of recipients (Recipients 7, 9, and 13),
airborne transmissible IAVs were mainly transmitted from the
upper respiratory tract and not from the trachea and lungs of
donor ferrets.
Airborne IAVs infect the ferret nasal respiratory epithelium.
Next, the cell tropism in the URT that promotes airborne
transmission was investigated. The URT is composed of the nasal
turbinates (which comprises the nasal respiratory epithelium and
the olfactory epithelium), paranasal sinuses, pharynx and the
larynx. In a previous study, it was observed that human IAVs (A/
H1N1 A/Netherlands/602/2009 and A/H3N2 A/Netherlands/
177/2008), in contrast to the avian A/H5N1 virus (A/Indonesia/5/
2005), abundantly infected the nasal respiratory epithelium of
ferrets, located in the rostral part of the nasal turbinates, upon
intranasal inoculation34. In ferrets inoculated with A/H1N1 and
A/H3N2 viruses, the nasal respiratory epithelium was infected as
early as 1 dpi, the lining epithelium was damaged because of the
infection and start of regeneration of the epithelium was observed
at 3 dpi. In order to understand whether this nasal respiratory
tropism was a common trait of airborne-transmissible inﬂuenza
viruses, immunohistochemical stainings were performed on nasal
turbinates, collected at 2 dpi, of three ferrets inoculated with
either A/H5N1AT or A/H5N1, as a control. The time point 2 dpi
was chosen based on the observation that regeneration of the
epithelium was observed as early as 3 dpi in ferrets inoculated
with A/H1N1 and A/H3N2 viruses. The percentage of epithelium
that was antigen-positive in the nasal respiratory and olfactory
epithelia, as well as the infectious virus titers in the homogenized
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Fig. 1 The A/H1N1 virus was transmitted from the upper respiratory tract of ferrets. Donor ferrets 1 and 2 were inoculated intranasally with 105 TCID50
of the A/H1N1 virus (shown in red) and intratracheally with 105 TCID50 of the A/H1N1var virus (shown in blue). Donor ferrets 3 and 4 were inoculated with
the opposite placement of viruses. Recipient ferrets were added to the adjacent cage at 4 hpi. Virus titers in the nose and throat swabs were determined by
TCID50 assay and are indicated on the y-axis. The limit of detection of the virus titration is shown by the dotted line. The proportions of untagged (red) and
tagged (blue) viruses, as determined by next-generation sequencing on the PB2 gene, are indicated by the colored bars. The gray bars correspond to
samples that were not included in the next-generation sequencing. Source data are provided as a Source Data ﬁle.
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nasal turbinates tissue (containing both nasal respiratory and
olfactory epithelia), were determined. Data from our previous
study on A/H1N1 and A/H3N2 viruses were included in the
analysis34. At 2 dpi, airborne transmissible A/H1N1, A/H3N2
and A/H5N1AT viruses had infected on average 55%, 43% and
37% of the nasal respiratory epithelium, whereas the A/H5N1
virus was detected in only 2% of the epithelium (Fig. 3a, b). At 1
dpi, 90% and 30% of the respiratory epithelium was infected by
A/H1N1 and A/H3N2 viruses respectively (Fig. 3b), highlighting
differences in infection kinetics between the two viruses.
At 2 dpi, the nasal olfactory epithelium was less infected by
the airborne transmissible A/H1N1, A/H3N2 and A/H5N1AT
viruses than the nasal respiratory epithelium (40%, 0% and 7%
respectively). In contrast, more cells of the nasal olfactory
epithelium were infected by the A/H5N1 virus than of the
respiratory epithelium (18% and 2% respectively). Given these
observations, it appears unlikely that tropism in the nasal
olfactory epithelium plays a role in airborne transmission of
IAVs. Infectious virus titers in the nasal turbinates did not reﬂect
these differences, partially because the homogenized nasal
turbinate sample contained both nasal respiratory and olfactory
epithelia (Fig. 3c). Mean virus titers in nasal turbinates of ferrets
inoculated with A/H3N2 were lower than those in ferrets
inoculated with A/H1N1, A/H5N1AT and A/H5N1. Moreover,
despite infecting a lower percentage of cells, the A/H5N1 virus
replicated to high virus titers in the nasal turbinates. Together,
these data suggest that infection of the nasal respiratory
epithelium, rather than replication to high titers in the nasal
turbinates, is a driver of airborne transmission. The availability of
genetically close viruses with distinct infection phenotypes in the
nose of ferrets (A/H5N1AT and A/H5N1) provided an excellent
opportunity to investigate the substitutions that were responsible
for the nasal respiratory epithelium tropism. To this end, subsets
of mutations that are present in A/H5N1AT were introducted into
the A/H5N1 background. Recombinant viruses carrying either
the substitutions in the polymerase and the nucleoprotein genes
(A/H5N1POL-mut, containing PB2-E627K, PB1-H99Y, PB1-I368V,
NP-R99K, NP-S345N) or the substitutions in the HA gene (A/
H5N1HA-mut containing HA-H103Y, HA-T156A, HA-Q222L,
HA-G224S (A/H5 numbering throughout the manuscript35))
were produced using reverse genetics and used to inoculate three
ferrets intranasally. Two days after inoculation, the animals were
euthanized. The percentage of epithelium that was antigen-
positive in the nasal respiratory and olfactory epithelia was
scored and infectious virus titers in the homogenized nasal
turbinates tissue were determined. Eighty-eight percent of the
nasal respiratory epithelial cells of ferrets inoculated with
A/H5N1HA-mut were infected, against 13% for ferrets inoculated
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Fig. 2 A/H1N1, A/H3N2 and A/H5N1AT viruses were transmitted from the upper respiratory tract of ferrets. Ferrets were inoculated with 105 TCID50 of
untagged (shown in red) and tagged (shown in blue) virus pairs of A/H1N1 virus (a Donors 5–8), A/H3N2 virus (b Donors 9–12) or A/H5N1AT virus
(c Donors 13–16). Untagged and tagged viruses were inoculated either intranasally or intratracheally as indicated by the color coding in the schematic ferret
representations. Untagged and tagged virus proportions at the day of virus transmission are represented by the pie charts for both donor and recipient
ferrets. URT: upper respiratory tract, i.e., nasal turbinates, LRT: lower respiratory tract, i.e., combined data from two parts of the trachea and the lungs, N:
nose swabs, T: throat swabs. X means that no transmission was observed. Transmission was deﬁned by the detection of two consecutive swabs with a RT-
qPCR threshold (CT-value) of 35. Source data are provided as a Source Data ﬁle.
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Fig. 3 Airborne transmissible inﬂuenza A viruses infected the nasal respiratory epithelium of ferrets. a Representative pictures of ferret nasal
respiratory and nasal olfactory epithelia 2 days after intranasal inoculation with A/H1N1, A/H3N2, A/H5N1AT or A/H5N1 viruses. Inﬂuenza A virus
nucleoprotein expression was determined by immunohistochemistry (IHC) and is shown as a red stain. HE: hematoxylin-eosin stain. Scale bar 50 μm.
b Percentage of epithelium that was nucleoprotein antigen-positive, as determined by IHC, were blindly assessed in the nasal respiratory epithelium (black)
and nasal olfactory epithelium (light gray) of three ferrets inoculated with the respective viruses. Individual percentages are shown. Means are depicted by
the horizontal lines. c Individual virus titers in the homogenized nasal turbinates (containing both nasal respiratory and olfactory epithelia) were determined
by end-point titration in MDCK. Means are depicted by the horizontal lines. The limit of detection of the virus titration is shown by the dotted line. Source
data are provided as a Source Data ﬁle.
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with A/H5N1POL-mut (Supplementary Fig. 5). Using combinations
of the four HA substitutions, we subsequently found that
receptor-binding substitutions Q222L/G224S alone were not
sufﬁcient to confer a similar nasal respiratory epithelium tropism
as that of A/H5N1AT. However, when Q222L and G224S were
combined with either H103Y or T156A, the percentage of nasal
respiratory epithelium that was infected was similar or higher to
that of A/H5N1AT (Supplementary Fig. 5, Panel a and b).
Comparable to our previous observations, all viruses replicated to
similar titers in the nasal turbinates, independent of the
percentage of infected nasal respiratory and olfactory epithelium.
Airborne IAVs infect human nasal respiratory epithelial cells.
To allow extrapolation of results from ferrets to humans, it was
investigated whether airborne transmissible IAVs also pre-
ferentially infect human nasal respiratory epithelial cells. Primary
human nasal epithelial cells (MucilairTM) were purchased from
Epithelix Sárl. These cells were isolated from 14 healthy donors
who underwent polypectomy, pooled, and fully differentiated at
the air-liquid interface on a transwell membrane for 45 days.
They contain the cell types present in the nasal respiratory epi-
thelium: ciliated cells, mucus-producing goblet cells and basal
cells. However, the origin of the respiratory epithelium, i.e., nasal
conchae or nasopharynx, is unknown. First, in order to under-
stand whether these primary human nasal epithelial cells can be
used as a model for human nasal epithelial tissue, the binding
pattern of human (A/H1N1 and A/H3N2), avian (A/H5N1) and
modiﬁed avian (A/H5N1Q222L/G224S) inﬂuenza viruses to these
cells was determined using virus histochemistry (Supplementary
Fig. 6). Ferret nasal turbinates and duck colon tissues were used
as controls for the binding of human and avian inﬂuenza viruses
respectively. A/H1N1, A/H3N2, and A/H5N1Q222L/G224S viruses
abundantly attached to the apical side of ciliated epithelial cells, as
previously described21,27. The A/H5N1 virus occasionally
attached to ciliated epithelial cells, as observed in the human
nasopharynx27, suggesting that at least a proportion of the cells
might be derived from human nasopharynx rather than human
nasal conchae.
A/H1N1, A/H3N2, A/H5N1, and A/H5N1AT viruses were then
used to inoculate the primary human nasal epithelial cells in
duplicate. Two transwell membranes per virus were ﬁxed in
formalin 1, 2 or 3 days after inoculation and infected cells were
stained by immunohistochemistry detecting the nucleoprotein
(Fig. 4). The human A/H1N1 virus abundantly infected the
ciliated nasal epithelial cells and, three days after inoculation, all
ciliated epithelium was damaged due to the infection. The A/
H3N2 virus infected the ciliated epithelial cells to a lesser extent
than the A/H1N1 virus, as observed in the ferret nasal turbinates.
However, by 3 dpi, part of the ciliated epithelium exhibited
shortened or destroyed cilia, as the result of infection. In contrast,
the A/H5N1 virus only infected ciliated epithelial cells occasion-
ally, and the infection did not progress during the course of the
experiment. The infection phenotype of the A/H5N1AT virus was
intermediate to that of A/H3N2 and A/H5N1 viruses. These
results showed that, as observed in ferrets, human airborne
transmissible IAVs also abundantly infected in primary human
nasal respiratory epithelial cells, in contrast to the non-airborne
transmissible inﬂuenza A/H5N1 virus.
Discussion
IAVs can be transmitted via non-mutually exclusive routes of
transmission: direct contact, indirect contact, respiratory droplets,
or aerosols. However, the relative contribution of each route to
efﬁcient IAV transmission remains unknown and under debate.
Respiratory droplet transmission is mediated by expelled particles
that have a propensity to settle quickly because of their size and is
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Fig. 4 Airborne transmissible inﬂuenza A viruses infected the human respiratory epithelium. Representative pictures of primary cultures of human nasal
respiratory epithelium (MucilairTM) inoculated with A/H1N1, A/H3N2, A/H5N1AT, A/H5N1 viruses or PBS (Mock). Inﬂuenza A virus nucleoprotein
expression was determined by immunohistochemistry (IHC) and is shown as a red stain. Scale bar 100 μm.
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therefore reliant on close proximity between infected (donor) and
susceptible (recipient) individuals, usually within 1 m of the site
of expulsion36. Aerosol transmission is mediated by expelled
particles that are smaller in size than respiratory droplets and can
remain suspended in the air for prolonged periods of time,
allowing infection of susceptible individuals at a greater distance
from the site of expulsion. A generally accepted cut-off size to
discriminate between respiratory droplets and aerosols is 5 µm
diameter37. The current paradigm adopted by the Word Health
Organization (WHO) is that inﬂuenza viruses are transmitted via
respiratory droplets, when aerosol-generating procedures are
excluded37. Therefore, current guidelines to prevent inﬂuenza
virus transmission in health care settings are only based on
preventing respiratory droplet transmission (summarized in
ref. 38). However, the recent body of work on the detection of
inﬂuenza virus genomes and infectious particles in aerosols sug-
gests that IAVs are also transmitted by aerosols4–15. This dis-
cordance between guidelines and experimental data highlights the
urgent need to improve our fundamental understanding of
inﬂuenza virus transmission. One current gap in this under-
standing is the identiﬁcation of the anatomical site of the
respiratory tract from which inﬂuenza virus-laden particles are
generated and expelled for onwards transmission. It has been
shown that preference of the virus to bind to α2,6-SA, associated
with viral replication in the ciliated cells in the URT (nasal tur-
binates, pharynx, larynx) and part of the LRT (trachea,
bronchus), is an important determinant for airborne transmissi-
bility of IAVs23–25. However, it still remained unknown whether
the source of exhaled viruses from the donor is the epithelium of
tissues in the URT, the LRT or both, and whether α2,6-SA
binding preference is necessary for the virus to be exhaled from
the donor or for the virus to initiate replication in the recipient.
Here, it was shown for the ﬁrst time that human A/H1N1 and
A/H3N2 viruses and mammal-adapted avian A/H5N1 virus are
transmitted via the air from the URT, more speciﬁcally from the
nasal respiratory epithelium, and not from the trachea, bronchus
or the lungs of inoculated ferrets. Transmission was delayed and
less robust than observed in previous experiments, in which the
donor ferret is only inoculated intranasally and stay in contact
with the recipient ferret for 14 days (rather than maximum
5 days)18,32. The reason for this might be the fact that the donor
ferrets were suffering from lower respiratory tract disease, pos-
sibly leading to impaired breathing, or that the donor ferrets were
removed from the experiment in some cases too early.
The results of this study imply that replication in the URT of
ferrets, and more speciﬁcally the nasal respiratory epithelium, is
important for the generation and expulsion of inﬂuenza virus-
laden particles from donor ferrets. As particles expelled from the
URT are thought to be bigger than those expelled from the LRT,
the results of this study could imply that transmission of IAVs
between ferret is mediated by respiratory droplets rather than
aerosols, which is in accordance with the studies by Zhou et al.39
and Gustin et al.40. Zhou et al.39 showed that naive or inﬂuenza-
inoculated ferrets exhaled a greater number of ﬁne particles
(<1.5 µm) than large particles but that viral RNA was pre-
dominantly present in particles > 4 µm. Consistent with this
observation, transmission between ferrets was abolished when
particles > 1.5 µm were captured by a size impactor. Gustin et al.40
also showed that viable virus detection in inoculated ferret breath
was ﬁve times higher in particles > 4.7 µm than in particles
<4.7 µm. Isolation of infectious virus from aerosols expelled by
infected individuals4,7,11,14 gave rise to the hypothesis that
inﬂuenza virus-laden particles are more likely to originate from
the deepest parts of the lungs, where small aerosol particles are
hypothesized to be generated by the reopening of collapsed small
airways during the previous inhalation41–45, than from the upper
or oropharyngeal airways4,6,7. This hypothesis is in contradiction
with the results of this study. However, evaporation of respiratory
droplets generated in the upper respiratory tract could lead to
transmission via aerosols. Collection of viable inﬂuenza virus
from the air and accurate determination of particle size, because
of the rapid evaporation of droplets and aerosols, remain difﬁcult.
Improvement of respiratory droplet and aerosol collection tech-
niques that preserve the size and infectivity of the virus particles is
greatly needed. Moreover, once inﬂuenza viruses are expelled
from the donor, they must remain stable in aerosols/respiratory
droplets to be able to initiate a new infection in the recipient.
Chemo-physical properties of both the air and the particles,
including temperature, ultraviolet radiation, humidity and air
movement inﬂuence the virus stability and infectivity46. In
addition, the rate of evaporation of aerosols is higher than that of
droplets, which might impact virus survival. After the airborne
phase, the size of aerosols and droplets will determine the region
of deposition: whereas droplets tend to be deposited in the URT,
aerosols can be inhaled and deposited deep in the LRT47.
Moreover, deposition needs to take place in a part of the
respiratory tract where appropriate receptors are expressed,
which is the case for the URT where α−2,6-SA are prevalent28,29.
The site of infection initiation in the recipient upon transmission
via the air remains unknown. In ferret transmission experi-
ments18,21,32,48, throat swabs of recipient ferrets usually become
virus-positive before nose swabs, suggesting that virus deposition
and infection is initiated in the oropharyngeal cavity. This would
be consistent with transmission being mediated by respiratory
droplets that would be generated in the URT of donor ferrets and
deposited in the URT of recipient ferrets. The soft palate, forming
the ﬂoor of the nasopharynx in the oropharyngeal cavity, has
been recently identiﬁed as a potential site for the selection of
airborne transmissible viruses that bind to long-chain α−2,6-SA
and it was suggested that it could be the initial site of infection
upon airborne transmission49.
Despite the observation that airborne transmissible IAVs are
transmitted from the URT of inoculated ferrets, the exact site of
particle generation within the URT remains unknown. In the ﬁrst
set of experiments, only the nasal turbinates were collected, and it
cannot be excluded that airborne transmissible IAVs were
transmitted from the throat (pharynx, larynx). However, even
when the virus inoculated in the LRT was detected in throat
swabs of donor ferrets, it was never transmitted as the dominant
variant to recipient ferrets, suggesting that inﬂuenza virus-laden
particles were not expelled from the oropharyngeal cavity of
donor ferrets. All inﬂuenza viruses tested in this study replicated
to high titers in the nasal turbinates of inoculated ferrets, how-
ever, clear differences in tropism within the nasal turbinates tissue
were observed. A/H1N1, A/H3N2, and A/H5N1AT viruses
abundantly infected the nasal respiratory epithelium of ferrets,
contrary to avian A/H5N1 virus, supporting the hypothesis that
airborne transmissible viruses are expelled from the nasal
respiratory epithelium. Interestingly, although A/H5N1 virus only
infected cells in the nasal olfactory epithelium, virus infectious
titers in the homogenized nasal turbinate tissue were in the same
range as those of A/H1N1 and A/H5N1AT viruses. In a recent
study, infection of primary differentiated ferret nasal epithelial
cells by avian A/H5N1 virus resulted in higher virus titers and
more cell damage as compared to human A/H1N1 virus50.
However, these differentiated primary ferret nasal epithelial cell
cultures contained cells derived from both the respiratory and
olfactory epithelia, potentially explaining why A/H5N1 virus
replicated to higher titers than A/H1N1. In our study, the nasal
respiratory epithelium tropism of A/H5N1AT virus was mediated
by substitutions in the HA promoting binding to α−2.6-SA and/
or stability. This change in tropism of the A/H5N1AT virus was
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less obvious when assessed in primary human nasal respiratory
epithelial cells, which might reﬂect the fact that A/H5N1AT virus
was primarily adapted to transmit between ferrets. However,
differences in infectivity in the human nasal respiratory epithe-
lium between human and avian viruses were very clear, sup-
porting the hypothesis that the nasal cavity could also be the
preferred site for generation and expulsion of airborne trans-
missible inﬂuenza virus-laden particles in humans. Measuring the
generation of inﬂuenza virus-laden particles upon breathing via
the nose or the mouth separately would help in validating or
inferring this hypothesis.
Here we propose a transmission model in which inﬂuenza
virus-laden respiratory droplets are expelled from the nasal
respiratory epithelium of the donor and deposited in the oro-
pharyngeal cavity of the recipient. Virus replication is then
initiated in the oropharyngeal cavity of the recipient after which
the virus spreads to the nasal respiratory epithelium, from where
it can be expelled for onwards transmission via the air. Should
this model be correct, simple measures that target the URT to
block transmission of IAVs could be implemented in health care
settings. Continued efforts are necessary to fully understand the
tropism of IAVs in humans in relation to airborne transmission,
which will help to improve prevention measures in health care
settings.
Methods
Cells. Madin-Darby canine Kidney (MDCK) cells (ATCC) were cultured in Eagle’s
minimal essential medium (EMEM, Lonza Benelux BV, Breda, the Netherlands)
supplemented with 10% foetal bovine serum (FBS) (Greiner), 100 Uml−1 penicillin
(PEN, Lonza), 100 Uml−1 streptomycin (STR, Lonza), 2 mM L-glutamine (L-glu,
Lonza), 1.5 mg ml−1 sodium bicarbonate (NaHCO3, Lonza), 10 mM Hepes (Lonza)
and 1X non-essential amino acids (NEAA, Lonza). 293T cells (ATCC) were cul-
tured in Dulbecco modiﬁed Eagle’s medium (DMEM, Lonza) supplemented with
10% FBS, 100 Uml−1 PEN, 100 Uml−1 SRT, 2mM L-glu, 1 mM sodium pyruvate
(Gibco) and 1X NEAA. Human airway epithelia reconstituted in vitro (Muci-
lAirTM, EP02MP) were purchased from Epithelix Sàrl (Switzerland).
Viruses. Untagged and tagged variant (var) recombinant A/Netherlands/602/2009
(A/H1N1) viruses were were initially described in ref. 30. The tagged A/H1N1var
virus carries a single synonymous nucleotide substitution per segment relative to
the untagged A/H1N1 virus, as follows (nucleotide numbering is from the 5′ end of
the cRNA): PB2 C273T, PB1 T288C, PA C360T, HA C305T, NP A351G, NA
G336A, M G295A, NS C341T. These substitutions were introduced into the reverse
genetics plasmids using QuikChange (Agilent) site directed mutagenesis, according
to the manufacturer’s instructions (for a complete list of the primers used in this
study, see Supplementary Table 2). An 8 plasmid rescue system based on a
modiﬁed version of pHW200051 and co-culture of 293T and MDCK cells were
used. Plaque isolates derived from rescue supernatants were ampliﬁed in MDCK
cells to generate virus stocks and stock titers were determined by endpoint titration
in MDCK cells.
Untagged and tagged variant (var) recombinant A/Panama/2007/99 (A/H3N2)
viruses were initially described in ref. 33. The tagged A/H3N2var virus contains the
following synonymous nucleotide substitutions relative to the untagged A/H3N2
virus: PB2 C354T, C360T; PB1 A540G; PA A342G, G333A; HA T308C, C311A,
C314T, A464T, C467G, T470A; NP C537T, T538A, C539G; NA C418G, T421A,
A424C; M G586A; NS C329T, C335T, A341G. These mutations were introduced
into the pPOL1 reverse genetics plasmids using QuikChange (Agilent) site directed
mutagenesis, according to the manufacturer’s instructions. For A/H3N2 viruses, a
12 plasmid rescue system based on pPOL1 and pCAGGS vectors and co-culture of
293T and MDCK cells were used. Plaque isolates derived from rescue supernatants
were ampliﬁed in 11-day-old embryonated chicken eggs incubated at 33oC to
generate virus stocks and stock titers were determined by endpoint tirations in
MDCK cells.
Recombinant airborne transmissible A/H5N1 A/Indonesia/05/2005 virus
(A/H5N1AT) was initially described in ref. 21. The A/H5N1AT virus carries 9 amino
acid substitutions as compared to the A/H5N1 virus (A/H5N1): PB2-E627K, PB1-
H99Y, PB1-I368V, NP-R99K, NP-S345N, HA-H103Y, HA-T156A, HA-Q222L,
and HA-G224S. The var A/H5N1AT virus carries one silent nucleotide substitution
in the PB2 gene (A339G), which was introduced into the reverse genetics plasmids
using QuikChange (Agilent) site directed mutagenesis, according to the
manufacturer’s instructions. Recombinant A/H5N1 viruses carrying subsets of
airborne substitutions were initially described in ref. 21. Airborne substitutions
were introduced into the reverse genetics plasmids using QuikChange (Agilent) site
directed mutagenesis, according to the manufacturer’s instructions. A/H5N1
viruses used for virus histochemistry were recombinant viruses with seven gene
segments of A/Puerto-Rico/8/1934 and the wild-type or mutant HA segment
(A/H5N1HA-Q222L/G224S) of A/Indonesia/5/2005 from which the multibasic cleavage
site was removed. Recombinant A/H5 inﬂuenza viruses were rescued in 293T cells
by using reverse genetics using a modiﬁed version of pHW200051. Cells were plated
the day before transfection in gelatinized 100 mm diameter culture dishes to obtain
50% conﬂuent monolayers. 293T cells were then transfected using calcium
phosphate with 40 μg of total DNA. After overnight transfection, the transfection
medium was replaced with fresh medium supplemented with 2% FCS for virus
production. Cells were incubated for 72 h, after which supernatants were harvested.
Virus-containing supernatants were cleared by centrifugation for 10 min at 300 × g
and used to infect MDCK to generate virus stocks and stock titers were determined
by endpoint tirations in MDCK cells. The A/H3N2 A/Netherlands/213/2003 and
A/H1N1 A/Netherlands/602/2009 viruses used for virus histochemistry were
human isolates propagated in MDCK cells.
Biosafety. Experiments with A/H1N1 and A/H3N2 viruses were performed under
biosafety level 3 conditions and experiments with A/H5N1 were performed under
biosafety level 3+ conditions. Experiments with A/H5N1AT were conducted in
adherence with the conditions of the U.S. Government Gain-of-Function Delib-
erative Process and Research Funding Pause of Selected Gain-of-Function Research
involving Inﬂuenza, MERS and SARS viruses52.
Ferret experiments. All relevant ethical regulations for animal testing have been
complied with. Animals were housed and experiments were performed in strict
compliance with European guidelines (EU Directive on Animal Testing 86/609/
EEC) and Dutch legislation (Experiments on Animals Act, 1997). Inﬂuenza virus
and Aleutian Disease Virus seronegative 6-month-old female ferrets (Mustela
putorius furo), weighing 700–1000 g, were obtained from commercial breeders
(Euroferret (Denmark) and TripleF (USA)). All animal experiments received
ethical approval from the independent animal experimentation ethical review
committee ‘stichting DEC consult’ (Erasmus MC permit number 122-11-30 and
122-14-13). The DEC considers the application and pays careful attention to the
effects of the intervention on the animal, its discomfort and weighs this against the
social and scientiﬁc beneﬁt to humans or animals. The researcher is required to
keep the effects of the intervention to a minimum, based on the three Rs
(Reﬁnement, Replacement, Reduction). Animal welfare was monitored on a daily
basis. Virus inoculation of ferrets was performed under anesthesia with a mixture
of ketamine/medetomidine (10 and 0.05 mg kg−1 respectively) antagonized by
atipamezole (0.25 mg kg−1). All animal handling (swabbing and weighing) was
performed under light anesthesia using ketamine to minimize animal suffering.
(i) Ferret transmission experiments: Donor ferrets were inoculated
intratracheally with 105 TCID50 of virus diluted in a 3 ml volume of phosphate-
buffered saline (PBS) and subsequently intranasally with 105 TCID50 of virus
diluted in a 40 μl volume of PBS (20 μl instilled in each nostril). Half of the donor
ferrets were inoculated with untagged viruses intranasally and tagged viruses
intratracheally and the other half with the opposite placement of virus in order to
correct for potential small differences in transmissibility (see Supplementary
Table 1 for a summary). Throat and nose swabs were collected from donor ferrets
every day until 7 days post inoculation (dpi) (donor ferret 1–4) or until the day
transmission was observed or the latest at 5 dpi (donor ferrets 5–16). Recipient
ferrets were placed four hours after inoculation (hpi) of donor ferrets in an
opposite cage separated by two steel grids, 10 cm apart, to avoid contact
transmission. Throat and nose swabs were collected from recipient ferrets 12 h
respectively until 9 days post exposure (dpe). Swabs were stored at −80 °C in
transport medium (Hanks’ balanced salt solution containing 0.5% lactalbumin
(Sigma-Aldrich), 10% glycerol (Sigma-Aldrich), 200 Uml−1 PEN, 200 mgml−1
STR, 100 Uml−1 polymyxin B sulfate (Sigma-Aldrich), and 250 mgml−1
gentamicin (Gibco)) for end-point titration in MDCK and next-generation
sequencing as decribed below. Shedding from recipient ferrets 5–16 was monitored
every day by performing real-time RT-qPCR detecting the matrix gene on nose and
throat swabs right after collection as described below. The rest of the swabs were
stored in transport media at −80 °C for endpoint titration in MDCK cells and next-
generation sequencing. The corresponding donor ferrets were euthanized by heart
puncture under anesthesia when transmission to the recipient ferret was observed
(two consecutive positive swabs with a threshold value in RT-qPCR (CT value)
< 35) or at 5 dpi the latest. Samples from the respiratory tract (nasal turbinates,
upper part of the trachea, lower part of the trachea, left lung lobes and right lung
lobes) were collected, homogenized in transport medium using a FastPrep system
(MP Biomedicals) with 2 one-quarter-inch ceramic sphere balls, centrifuged at
1500 × g for 10 min, aliquoted, and stored at −80 °C for endpoint titration in
MDCK cells and next-generation sequencing. Additionally, throat and nose swabs
were collected from donor ferrets 5–16 every day until euthanasia and stored in
transport media at −80 °C for endpoint titration in MDCK cells and next-
generation sequencing. Clonality of the virus inoculum was conﬁrmed by next-
generation sequencing. Virus inocula were back titrated to ensure that the right
doses were used to inoculate donor ferrets.
(ii) Ferret infection experiments: Three ferrets per group were inoculated
intranasally with a total dose of 106 TCID50 of virus by instillation of 250 μl of virus
suspension dropwise in each nostril. The A/H5N1 viruses tested carried subsets of
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airborne substitutions: A/H5N1POL-mut (PB2-E627K, PB1-H99Y, PB1-I368V, NP-
R99K, NP-S345N), A/H5N1HA-mut (HA-H103Y, HA-T156A, HA-Q222L and HA-
G224S), A/H5N1HA-Q222L/G224S, A/H5N1HA-H103Y/Q222L/G224S, A/H5N1HA-T156A/
Q222L/G224S. Two days after inoculation, ferrets were euthanized by cardiac puncture
and nasal turbinates were harvested. The left nasal turbinates were ﬁxed in 10%
neutral-buffered formalin, embedded in parafﬁn and sectioned at 3μm for
immunohistochemical analysis. The right nasal turbinates were homogenized in
transport medium using a FastPrep system (MP Biomedicals) with 2 one-quarter-
inch ceramic sphere balls, centrifuged at 1500 × g for 10 min, aliquoted, and stored
at −80 °C for endpoint titration in MDCK cells.
Immunohistochemistry. Sequential slides of nasal turbinates were deparafﬁnised
in xylene and hydrated using graded alcohols. They were stained with hematoxylin
and eosin (HE staining) or for the detection of the IAV nucleoprotein as described
here. Antigen retrieval was performed using a 0,1% solution of the protease from
Streptomycus griseus (Sigma-Aldrich) in PBS for 10 min at 37 °C. After a wash in
PBS, endogenous peroxidases were blocked by using a solution of 3% H2O2 in PBS
for 10 min at room temperature. After one wash in PBS and one wash in PBS-
0.05% Tween, slides were incubated with a monoclonal antibody against IAV
nucleoprotein (mouse IgG2a anti-inﬂuenza A nucleoprotein, H16-L10-4R5
(ATCC® HB-65™) diluted 1/400 in PBS-0,1% bovine serum albumin (BSA) or with
an isotype control (mouse IgG2a, MAB003, R&D Systems) diluted 1/200 in PBS-
0.1% BSA for an hour at room temperature. After two washes in PBS-0.05% Tween,
slides were incubated with a secondary antibody goat anti-mouse IgG2a coupled to
horseradish peroxidase (HRP) (Biorad, Star133P) diluted 1/100 in PBS-0.1% BSA
for an hour at room temperature. After two washes with PBS, HRP was revealed
using 3-Amino-9-Ethylcarbazole (AEC, Sigma-Aldrich) in N,N-dimethylforma-
mide (Honeywell Fluka) diluted in a ﬁnal concentration of 0.0475M of sodium
acetate (NaAc, pH= 5) with 0.05% of H2O2 for 10 min at room temperature,
resulting in a bright red precipitate. A counterstain was performed with hema-
toxylin and the slides were embedded using Kaiser’s glycerol gelatin (Merck). In
each staining procedure, a lung section from a cat infected experimentally with an
A/H5N1 virus was used as a positive control. Immunohistochemical analyses were
performed blindly by a veterinary pathologist. One slide with all the nasal tissue
(including both respiratory and olfactory epithelium) was analysed per ferret. For
the scoring, all the ﬁelds available on each slide were analysed and a percentage
score was estimated for each slide. Pictures were taken using an Olympus BX41
microscope, an Olympus DP27 camera and acquisition Olympus CellSens entry
software. The white balance of the pictures was adjusted using Adobe Photoshop.
Next-generation sequencing. Viral RNA was extracted from respiratory swab
samples collected from donor or recipient ferrets and from organs of donor ferrets,
using the High Pure RNA Isolation kit (Roche) according to the manufacturer’s
instructions. RNA was subjected to reverse-transcription using Superscript III
(Invitrogen) and the following primer: AGCRAAAGCAGG. Amplicons from the
PB2 genes were generated by PCR from the cDNA using the following primers: A/
H1N1 (CGCACTCAGAATGAAGTGGA (F), GCCGAAGGTACCATGTTTCA
(R), amplicon size of 265 nucleotides), A/H3N2 (CATAGTAGTGCAGAAAT
GGTTCCGGAGAGA (F), CATAGTAGTGTTCGGCGTATCTTGACTTGA (R),
amplicon size of 239 nucleotides) and A/H5N1 (CATAGTAGTGTGGAGCAAG
ACAAATGATGC (F), CATAGTAGTGCTCCCACTTCATTTGGGAAA (R),
amplicon size 288 nucleotides). These fragments were sequenced using the Roche
454 GS Junior sequencing platform. The fragment library was created for each
sample according to the manufacturer’s protocol without DNA fragmentation (GS
FLX Titanium Rapid Library Preparation, Roche). The emulsion PCR (Ampliﬁ-
cation Method Lib-L) and GS Junior sequencing run were performed according to
instructions of the manufacturer (Roche). Sequence reads from the GS Junior
sequencing data were sorted by barcode and aligned to reference sequences using
CLC Genomics software 6.0.2. The sequence reads were trimmed at 30 nucleotides
from the 3′ and 5′ ends to remove all primer sequences. For quality control,
sequence reads were trimmed for Phred scores of less than 20. The threshold for
the detection of single nucleotide polymorphisms was manually set at 1% of the
total number of reads per sample. Results were then expressed as percentage of the
sum of the reads corresponding to the two possible nucleotides (untagged and
tagged).
Virus titrations. MDCK cells were inoculated with 10-fold serial dilutions of virus
stocks, nose swabs, throat swabs, or homogenized tissue samples. The cells were
washed with PBS 1 h after inoculation and cultured in infection medium, con-
sisting of EMEM supplemented with 100 Uml−1 PEN, 100 Uml−1 STR, 2 mM L-
Glu, 1.5 mg ml−1 NaHCO3, 10 mM HEPES, 1× NEAA, and 20 μg ml−1 trypsin (N-
tosyl-l-phenylalanine chloromethyl ketone [TPCK]-treated trypsin; Sigma-
Aldrich). Three days after inoculation, supernatants of cell cultures were tested for
agglutinating activity using turkey red blood cells (TRBCs) as an indicator of virus
replication. Infectious virus titers were calculated from four replicates each of the
homogenized tissue samples, nose swabs, and throat swabs and from ten replicates
of the virus stocks by the method of Reed and Muench53.
Real-time RT-PCR targeting the matrix gene. Viral RNA extraction was per-
formed using the High the High Pure RNA Isolation kit (Roche) according to the
manufacturer’s instructions. Real-time RT-PCR was performed using the TaqMan™
Fast Virus 1-Step Master Mix (ThermoFisher Scientiﬁc) and the following forward
primer, reverse primer and probe: AAGACCAATCCTGTCACCTCTGA, CAAA
GCGTCTACGCTGCAGTCC and 6-FAM TTTGTGTTCACGCTCACCGTGCC-T
AMRA. Ampliﬁcation and detection was performed on an ABI7700 (Thermo-
Fischer Scientiﬁc) using the following program: 5 min 50 °C, 20” 95 °C, [3” 95 °C,
31” 60 °C] × 45 cycles.
Infection of primary human nasal respiratory epithelial cells. Human airway
epithelia reconstituted in vitro (MucilAirTM) were purchased from Epithelix Sàrl
(Switzerland). These human respiratory epithelia were reconstituted from nasal
polyps obtained from patients undergoing surgical nasal polypectomy. At Epithelix
Sàrl, mixtures of cells originating from 14 donors were seeded in Transwell-COL
inserts and cultured at the air-liquid interface. After 45-days of culture, the epi-
thelia became fully differentiated with a pseudo-stratiﬁed architecture with the
three main types of cells: ciliated epithelial cells, mucus-producing goblets cells and
basal cells. Cells were tested negative for mycoplasma, HIV-1, HIV-2, hepatitis B
and C. Cells were received when fully differentiated, were cultured at 37 °C, 5%
CO2 and basal media was changed every two days. The total number of differ-
entiated cells was estimated to be 400,000 cells per well. Before the inoculation, cells
were incubated with PBS supplemented with Ca2+ and Mg2+ (100 mg/L of CaCl2
and 100 mg/L of MgCl2−6H20) for 45 min at 37 °C, 5%CO2 and subsequently
washed three times with PBS with Ca2+ and Mg2+. This treatment tightens the
junctions and removes the mucus accumulated at the apical surface of the cells.
Cells were then inoculated in duplicates with A/H1N1, A/H3N2 (A/Panama/2007/
99), A/H5N1 or A/H5N1AT viruses at a multiplicity of infection (m.o.i) of 0.1
TCID50/cell for three hours at 37 °C, 5%CO2. Cells were then washed three times
with PBS with Ca2+ and Mg2+ and then left at the air-liquid interface. At 1, 2 and
3 days after inoculation, cells were washed 5 times with PBS with Ca2+ and Mg2+
and ﬁxed in 10% buffered formalin, embedded in parafﬁn and sectioned at 3μm for
immunohistochemical analysis as described above for the ferret nasal respiratory
and olfactory epithelia. Each membrane was sliced at three different positions to
have a representation of the infection pattern on the overall membranes. Repre-
sentative pictures were taken using an Olympus BX51 microscope, an Olympus
ColorView IIIu camera and acquisition Olympus CellA software. The white balance
of the pictures was adjusted using Adobe Photoshop.
Virus histochemistry. The pattern of virus attachment to human nasal respiratory
epithelium was determined by virus histochemistry54. Formalin-ﬁxed, parafﬁn-
embedded sections from three uninfected control wells were deparafﬁnised in
xylene and hydrated using graded alcohols. Endogenous peroxidases were blocked
with 3% H2O2 diluted in PBS for 10 min at room temperature. After two washes
with PBS, a blocking step with a Tris-NaCl-blocking buffer (TNB buffer, 0.5% of
blocking reagent (Perkin Elmer) in 0.1 M Tris HCl, 0.15 M NaCl, pH= 7.5) for
30 min at room temperature was performed. Hundred hemagglutination units of
ﬂuorescin isothiocyanate (FITC)-labeled inﬂuenza viruses (A/H1N1, A/H3N2 A/
Netherlands/213/2003, A/H5N1, A/H5N1HA-Q222L/G224S) were incubated on the
slides overnight at 4 °C in TNB buffer. After two washes with PBS-0.05% Tween,
FITC was detected with a peroxidase-labelled rabbit–anti-FITC (DAKO, P5100)
diluted 1/100 in TNB buffer for 1 h at room temperature. After two washes with
PBS-0.05% Tween, the signal was ampliﬁed using a tyramide ampliﬁcation system
(Perkin-Elmer) according to the manufacturer’s instructions. After two washes
with PBS-0.05% Tween, slides were incubated with HRP coupled anti-streptavidin
antibody (DAKO, D0397) diluted 1/300 in TNB buffer for 30 min at room tem-
perature. After two washes with PBS, HRP was revealed using 3-Amino-9-
Ethylcarbazole (AEC, Sigma-Aldrich) in N,N-dimethylformamide (Honeywell
Fluka) diluted in a ﬁnal concentration of 0.0475M of sodium acetate (NaAc, pH=
5) with 0.05% of H2O2 for 10 min at room temperature, resulting in a bright red
precipitate. A counterstain was performed with hematoxylin and the slides were
embedded using Kaiser’s glycerol gelatin (Merck). Ferret nasal turbinates and duck
colon were included as controls for binding of human and avian viruses respec-
tively. Pictures were taken using an Olympus BX51 microscope, an Olympus
ColorView IIIu camera and acquisition Olympus CellA software. The white balance
of the pictures was adjusted using Adobe Photoshop.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data underlying Figs. 1, 2, 3b, 3c and supplementary Figs. S2, S3, S4, S5b, S5c are
provided as Source Data ﬁles. All other data are available from the corresponding author
(S.H.) on reasonable request.
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